Premier Manufacturer of Amlodipine 10mg, Valsartan 160mg & Hydrochlorothiazide 25mg Tablets

At Taj Pharma India, we excel in manufacturing and exporting Amlodipine 10mg, Valsartan 160mg & Hydrochlorothiazide 25mg Tablets, a proven combination therapy for hypertension control. Operating from a WHO-GMP-certified facility in Vapi, Gujarat, we are dedicated to delivering high-purity, potent, and consistent blood pressure medication to markets across India, Africa, the Middle East, and Latin America (LTAM).


Powerful Triple-Component Mechanism

Our tablets combine three potent cardiovascular agents:

  • Amlodipine (10mg): A calcium channel blocker that relaxes blood vessel muscles, improving arterial flow and reducing strain on the heart.
  • Valsartan (160mg): An angiotensin II receptor blocker (ARB) that prevents vessel constriction, thereby lowering blood pressure and protecting organs.
  • Hydrochlorothiazide (25mg): A thiazide diuretic that reduces blood volume by promoting sodium and water excretion, enhancing vascular relaxation and long-term pressure control.

This powerful triad addresses hypertension from multiple pathways, preventing associated complications like stroke, heart attack, and renal disease.


Clinical Benefits & Therapeutic Efficacy

  • Superior BP Reduction: Studies show this combination achieves sustained blood pressure control, reducing systolic and diastolic values more effectively than single agents.
  • Organ Protection: Amlodipine supports vascular health; Valsartan safeguards the heart and kidneys; Hydrochlorothiazide prevents fluid retention and oedema.
  • Improved Patient Adherence: A single-dose combination simplifies medication regimens, enhancing compliance and outcomes.
  • Electrolyte & Potassium Management: While effective, patients must monitor potassium levels—we emphasise professional guidance to manage risks such as hyperkalemia.

Adverse Reactions & Safety Measures

Patients should be aware of possible side effects, including:

  • Fluid retention: Foot or ankle swelling, breathing difficulty.
  • Electrolyte changes: Elevated potassium, dehydration from increased urination.
  • Allergic reactions: Skin rash, facial swelling, vision changes.
  • Cardiovascular impacts: Palpitations or irregular heartbeat.
  • Renal function changes: Valsartan may affect kidney function, requiring periodic kidney tests.

Our manufacturing process includes detailed patient information leaflets and guidance for monitoring, ensuring safe administration.


High-Quality Manufacturing & Regulatory Compliance

  • WHO-GMP-certified infrastructure with modern equipment.
  • Raw materials from ISO-approved suppliers.
  • Thorough testing for purity, potency, stability, and microbial safety.
  • Compliance with dossier requirements (CTD, ACTD) and COAs for international clients.
  • Private-label and custom-packaging options are tailored to specific regional regulations.

Distribution & Franchise Model

We offer:

  • PAN-India distribution across major cities and tier-2 regions.
  • International exports to Africa, the Middle East, and Latin America.
  • PCD Pharma Franchise offers partnership models with comprehensive marketing support and competitive pricing.
  • Bulk supply agreements for tenders, hospitals, and healthcare institutions.

Our logistics network ensures prompt delivery, maintaining product integrity and patient satisfaction.


Extended Therapeutic Applications

Beyond primary hypertension control, our triple-combination tablets support:

  • Resistant hypertension cases require multi-drug therapy.
  • Oedema management in conditions like congestive heart failure.
  • Renoprotection in patients with early-stage diabetic kidney disease.
  • Post-stroke cardiovascular care, in consultation with medical professionals.

Patient Guidance & Professional Monitoring

We include guidance to:

  • Avoid potassium-rich foods during treatment.
  • Report any muscle cramps, weakness, swelling, or irregular heartbeat.
  • Undergo regular blood tests for renal function, electrolytes, and blood pressure.
  • Discern symptoms of allergic or cardiovascular concerns, such as chest pain or breathing difficulties.

Why Taj Pharma Leads the Market

  1. Triple-Agent Expertise: Proficient formulation of three synergistic cardiovascular agents.
  2. Regulatory Strength: Full compliance and internationally accepted documentation.
  3. Global Reach: Trusted by clients in India, Africa, the Middle East, and Latin America.
  4. Flexible Partnership: PCD franchise, contract manufacturing, custom labelling.
  5. Cost Efficiency: Economical pricing without compromising on quality or standards.

About Taj Pharma India

  • Location: Vapi, Gujarat, India
  • Certifications: WHO-GMP, ISO, Dossier-ready
  • Formulation: Amlodipine 10mg / Valsartan 160mg / Hydrochlorothiazide 25mg
  • Packaging: Blister packs / Customised counting & labels
  • Shelf Life: Up to 36 months under standard storage
  • Supply Scope: PAN India, Africa, Middle East, LTAM

For superior blood pressure management, Taj Pharma India offers high-efficacy, triple-combination tablets backed by rigorous quality standards and reliable distribution. Our products support improved adherence, safety, and therapeutic success for healthcare providers and patients worldwide.